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CASE REPORT 
Chronic coagutopathy in a patient with argininosuccinase deficiency 
E. V. Bawle I and I. Warrier 2 
Argininosuccinase d ficiency (McKusick 20790) (ALD) is an autosomal recessively 
inherited inborn error of the urea cycle. The neonatal form presents with hyperam- 
monaemia nd encephalopathy. The survivors have intellectual impairment and 
varying degrees of hepatomegaly associated with mild abnormalities ofliver functions 
(Batshaw et al., 1982). Although the hepatomegaly is present in the first few weeks 
of life and the synthetic function of the liver is preserved, the long-term outcome for 
the liver is unknown (Flick et at., 1986). We report vitamin K non-responsive 
coagulopathy secondary to chronic liver disease in a patient with argininosuccinase 
deficiency. 
R. W., an 8-year-old girl, presented with hyperammonaemic coma and seizures on 
the third day of life. Diagnosis of ALD was based on markedly elevated plasma levels 
of argininosuccinic a id and mildly elevated citrulline. It was confirmed by fibroblast 
assay of argininosuccinase which showed only 4.8% of normal activity. She was 
rescued from the coma with exchange blood transfusion, mechanical ventilation and 
other supportive therapy. Her subsequent treatment has consisted of a low protein 
diet (1.25-2 g/kg/day) and supplementary arginine as the free base (0.5-0.75 g/kg/day). 
She has had numerous episodes of hyperammonaemia nifesting with seizures and 
lethargy, especially during intercurrent infections. She has been given sodium benzoate 
250 mg/kg/day during hyperammonaemic periods along with intravenous arginine. 
She remains table but has mild spastic erebral palsy, walks with a wide-based gait 
and has an IQ of 30. Her height is at the 3rd centile and weight and head circumference 
are at the 10th centile. Her peripheral blood count, total serum protein and albumin 
levels are normal. Her plasma ammonia ranges from 50-60/~mol/L (normal 24-48) 
and her plasma rgininosuccinic acid level ranges from 520-846 #mol/L. The alanine 
aminotransferase and aspartate aminotransferase levels fluctuate from 45-250 MU/ml, 
but serum bilirubin and alkaline phosphatase are normal. 
During the past two years prolonged bleeding at venipuncture sites prompted us 
to study her coagulation status. Prothrombin time (PT) was 16.7s (control 12.3), 
partial thromboplastin time (PTT) was 50.7 s (control 24-38) and thrombin time was 
12.9s (control 10.7-14.8). The fibrinogen level was 1.35g/L (normal 1.64-3.66). 
Prolongation of PT and PTT was persistent on several occasions. Her platelet count 
ranged from 200 x 10 9 to 290 x 109/L and the platelets appeared well clumped on 
the peripheral blood smear. No antibodies against hepatitis A, B, cytomegalovirus, 
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Epstein-Barr virus or human immune deficiency virus were detected. Activities of 
coagulation factors II (55% of normal), V (37% of normal), IX (47% of normal) and 
protein C antigens (63% of normal) were decreased, whereas activities of VII (95%) 
and X were normal. Fibrin split products were (1:5) negative. Inhibitor screen to 
detect a circulating anticoagulant was negative. Antithrombin (AT III) was normal 
(95%). 
PT and PTT did not show any improvement after intravenous administration f 
vitamin K or after transfusion with fresh frozen plasma (FFP). In fact, the PTT was 
further prolonged 2 and 24 h post-FFP transfusion and the plasma ammonia rose 
from 53 to 88/~mot/L in 2 h. 
To our knowledge, this is the first report of chronic oagutopathy in a patient with 
argininosuccinase deficiency. 18 children with ALD followed up to the age of 5 years 
were reported to have hepatomegaly and ultrastructural changes in hepatocytes but 
normal synthetic liver functions (Flick et al., 1986). Our patient has shown decreased 
synthesis of various coagulation factors in the liver independent of hyperammonaemia. 
We speculate that the argininosuccinase deficiency causes progressive liver disease 
and may eventually lead to liver failure. The increase in ammonia nd PTT after 
fresh frozen plasma transfusion suggests that the protein load of FFP aggravated the 
liver dysfunction. 
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